Cargando…
High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517516/ https://www.ncbi.nlm.nih.gov/pubmed/36141938 http://dx.doi.org/10.3390/ijerph191811664 |
_version_ | 1784798962164695040 |
---|---|
author | Nyawale, Helmut A. Moremi, Nyambura Mohamed, Mohamed Njwalila, Johnson Silago, Vitus Krone, Manuel Konje, Eveline T. Mirambo, Mariam M. Mshana, Stephen E. |
author_facet | Nyawale, Helmut A. Moremi, Nyambura Mohamed, Mohamed Njwalila, Johnson Silago, Vitus Krone, Manuel Konje, Eveline T. Mirambo, Mariam M. Mshana, Stephen E. |
author_sort | Nyawale, Helmut A. |
collection | PubMed |
description | The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus antibodies in the communities of three different districts in the Mwanza region, Tanzania. A household cross-sectional survey was conducted in September 2021 using the modified African Centre for Disease and Prevention (ACDC) survey protocol. A blood sample was obtained from one member of each of the selected households who consented to take part in the survey. Immunochromatographic rapid test kits were used to detect IgM and IgG SARS-CoV-2 antibodies, followed by descriptive data analysis. Overall, 805 participants were enrolled in the study with a median age of 35 (interquartile range (IQR):27–47) years. The overall SARS-CoV-2 seropositivity was 50.4% (95%CI: 46.9–53.8%). The IgG and IgM seropositivity of the SARS-CoV-2 antibodies was 49.3% and 7.2%, respectively, with 6.1% being both IgG and IgM seropositive. A history of runny nose (aOR: 1.84, 95%CI: 1.03–3.5, p = 0.036), loss of taste (aOR: 1.84, 95%CI: 1.12–4.48, p = 0.023), and living in Ukerewe (aOR: 3.55, 95%CI: 1.68–7.47, p = 0.001) and Magu (aOR: 2.89, 95%CI: 1.34–6.25, p= 0.007) were all independently associated with SARS-CoV-2 IgM seropositivity. Out of the studied factors, living in the Ukerewe district was independently associated with IgG seropositivity (aOR 1.29, CI 1.08–1.54, p = 0.004). Twenty months after the first case of COVID-19 in Tanzania, about half of the studied population in Mwanza was seropositive for SARS-CoV-2. |
format | Online Article Text |
id | pubmed-9517516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95175162022-09-29 High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey Nyawale, Helmut A. Moremi, Nyambura Mohamed, Mohamed Njwalila, Johnson Silago, Vitus Krone, Manuel Konje, Eveline T. Mirambo, Mariam M. Mshana, Stephen E. Int J Environ Res Public Health Article The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus antibodies in the communities of three different districts in the Mwanza region, Tanzania. A household cross-sectional survey was conducted in September 2021 using the modified African Centre for Disease and Prevention (ACDC) survey protocol. A blood sample was obtained from one member of each of the selected households who consented to take part in the survey. Immunochromatographic rapid test kits were used to detect IgM and IgG SARS-CoV-2 antibodies, followed by descriptive data analysis. Overall, 805 participants were enrolled in the study with a median age of 35 (interquartile range (IQR):27–47) years. The overall SARS-CoV-2 seropositivity was 50.4% (95%CI: 46.9–53.8%). The IgG and IgM seropositivity of the SARS-CoV-2 antibodies was 49.3% and 7.2%, respectively, with 6.1% being both IgG and IgM seropositive. A history of runny nose (aOR: 1.84, 95%CI: 1.03–3.5, p = 0.036), loss of taste (aOR: 1.84, 95%CI: 1.12–4.48, p = 0.023), and living in Ukerewe (aOR: 3.55, 95%CI: 1.68–7.47, p = 0.001) and Magu (aOR: 2.89, 95%CI: 1.34–6.25, p= 0.007) were all independently associated with SARS-CoV-2 IgM seropositivity. Out of the studied factors, living in the Ukerewe district was independently associated with IgG seropositivity (aOR 1.29, CI 1.08–1.54, p = 0.004). Twenty months after the first case of COVID-19 in Tanzania, about half of the studied population in Mwanza was seropositive for SARS-CoV-2. MDPI 2022-09-16 /pmc/articles/PMC9517516/ /pubmed/36141938 http://dx.doi.org/10.3390/ijerph191811664 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nyawale, Helmut A. Moremi, Nyambura Mohamed, Mohamed Njwalila, Johnson Silago, Vitus Krone, Manuel Konje, Eveline T. Mirambo, Mariam M. Mshana, Stephen E. High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey |
title | High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey |
title_full | High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey |
title_fullStr | High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey |
title_full_unstemmed | High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey |
title_short | High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey |
title_sort | high seroprevalence of sars-cov-2 in mwanza, northwestern tanzania: a population-based survey |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517516/ https://www.ncbi.nlm.nih.gov/pubmed/36141938 http://dx.doi.org/10.3390/ijerph191811664 |
work_keys_str_mv | AT nyawalehelmuta highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT moreminyambura highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT mohamedmohamed highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT njwalilajohnson highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT silagovitus highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT kronemanuel highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT konjeevelinet highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT mirambomariamm highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey AT mshanastephene highseroprevalenceofsarscov2inmwanzanorthwesterntanzaniaapopulationbasedsurvey |